• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床级再生医学的精准制造。

Precision manufacturing for clinical-quality regenerative medicines.

机构信息

Healthcare Engineering Group, Centre for Biological Engineering, Wolfson School of Mechanical and Manufacturing Engineering, Loughborough University, Loughborough LE11 3TU, UK.

出版信息

Philos Trans A Math Phys Eng Sci. 2012 Aug 28;370(1973):3924-49. doi: 10.1098/rsta.2011.0049.

DOI:10.1098/rsta.2011.0049
PMID:22802496
Abstract

Innovations in engineering applied to healthcare make a significant difference to people's lives. Market growth is guaranteed by demographics. Regulation and requirements for good manufacturing practice-extreme levels of repeatability and reliability-demand high-precision process and measurement solutions. Emerging technologies using living biological materials add complexity. This paper presents some results of work demonstrating the precision automated manufacture of living materials, particularly the expansion of populations of human stem cells for therapeutic use as regenerative medicines. The paper also describes quality engineering techniques for precision process design and improvement, and identifies the requirements for manufacturing technology and measurement systems evolution for such therapies.

摘要

工程创新在医疗保健领域的应用对人们的生活产生了重大影响。市场增长由人口统计学决定。良好制造规范的法规和要求——极高的可重复性和可靠性要求——需要高精度的工艺和测量解决方案。使用活生物材料的新兴技术增加了复杂性。本文介绍了一些工作成果,展示了活材料的精密自动化制造,特别是用于治疗再生医学的人类干细胞群体的扩增。本文还描述了用于精密工艺设计和改进的质量工程技术,并确定了此类治疗的制造技术和测量系统发展的要求。

相似文献

1
Precision manufacturing for clinical-quality regenerative medicines.临床级再生医学的精准制造。
Philos Trans A Math Phys Eng Sci. 2012 Aug 28;370(1973):3924-49. doi: 10.1098/rsta.2011.0049.
2
Current understanding and challenges in bioprocessing of stem cell-based therapies for regenerative medicine.再生医学中基于干细胞的治疗生物工艺学的当前认识和挑战。
Br Med Bull. 2011;100:137-55. doi: 10.1093/bmb/ldr037. Epub 2011 Aug 17.
3
Regenerative medicine. The industry comes of age.再生医学。该行业已走向成熟。
Med Device Technol. 2007 Mar-Apr;18(2):25-30.
4
Tissue engineering and regenerative medicine: manufacturing challenges.组织工程与再生医学:制造挑战
IEE Proc Nanobiotechnol. 2005 Dec;152(6):207-10. doi: 10.1049/ip-nbt:20050001.
5
50th anniversary of artificial cells: their role in biotechnology, nanomedicine, regenerative medicine, blood substitutes, bioencapsulation, cell/stem cell therapy and nanorobotics.人工细胞50周年:它们在生物技术、纳米医学、再生医学、血液替代品、生物包封、细胞/干细胞治疗及纳米机器人技术中的作用
Artif Cells Blood Substit Immobil Biotechnol. 2007;35(6):545-54. doi: 10.1080/10731190701730172.
6
Regenerative medicine.再生医学
Curr Probl Surg. 2011 Mar;48(3):148-212. doi: 10.1067/j.cpsurg.2010.11.002.
7
Regenerative medicine in dermatology: biomaterials, tissue engineering, stem cells, gene transfer and beyond.皮肤科的再生医学:生物材料、组织工程、干细胞、基因转移及其他。
Exp Dermatol. 2010 Aug;19(8):697-706. doi: 10.1111/j.1600-0625.2010.01087.x.
8
Future of regenerative medicine: challenges and hurdles.再生医学的未来:挑战与障碍。
Artif Organs. 2006 Oct;30(10):828-34. doi: 10.1111/j.1525-1594.2006.00307.x.
9
Regenerative medicine primer.再生医学入门。
Mayo Clin Proc. 2013 Jul;88(7):766-75. doi: 10.1016/j.mayocp.2013.04.017.
10
Cardiac cell therapy: bench or bedside?心脏细胞治疗:实验室研究还是临床应用?
Nat Clin Pract Cardiovasc Med. 2007 Aug;4(8):403. doi: 10.1038/ncpcardio0927.

引用本文的文献

1
Exploring bias risks in artificial intelligence and targeted medicines manufacturing.探索人工智能和靶向药物制造中的偏见风险。
BMC Med Ethics. 2024 Oct 17;25(1):113. doi: 10.1186/s12910-024-01112-1.
2
A quality-by-design approach to improve process understanding and optimise the production and quality of CAR-T cells in automated stirred-tank bioreactors.一种基于质量源于设计的方法,用于提高对自动化搅拌罐生物反应器中CAR-T细胞生产过程的理解,并优化其生产和质量。
Front Immunol. 2024 Apr 9;15:1335932. doi: 10.3389/fimmu.2024.1335932. eCollection 2024.
3
Advancing herbal medicine: enhancing product quality and safety through robust quality control practices.
推进草药医学:通过强有力的质量控制措施提高产品质量与安全性。
Front Pharmacol. 2023 Sep 25;14:1265178. doi: 10.3389/fphar.2023.1265178. eCollection 2023.
4
Natural killer cells in clinical development as non-engineered, engineered, and combination therapies.临床开发中的自然杀伤细胞作为非工程化、工程化和联合疗法。
J Hematol Oncol. 2022 Nov 8;15(1):164. doi: 10.1186/s13045-022-01382-5.
5
Gene therapy approaches for equine osteoarthritis.马骨关节炎的基因治疗方法。
Front Vet Sci. 2022 Sep 28;9:962898. doi: 10.3389/fvets.2022.962898. eCollection 2022.
6
Needle to needle robot-assisted manufacture of cell therapy products.针到针机器人辅助制造细胞治疗产品。
Bioeng Transl Med. 2022 Aug 6;7(3):e10387. doi: 10.1002/btm2.10387. eCollection 2022 Sep.
7
The evolution of synthetic receptor systems.合成受体系统的演变。
Nat Chem Biol. 2022 Mar;18(3):244-255. doi: 10.1038/s41589-021-00926-z. Epub 2022 Jan 20.
8
A blueprint for translational regenerative medicine.转化再生医学蓝图。
Sci Transl Med. 2020 Dec 2;12(572). doi: 10.1126/scitranslmed.aaz2253.
9
An Approach towards a GMP Compliant In-Vitro Expansion of Human Adipose Stem Cells for Autologous Therapies.一种用于自体治疗的符合GMP标准的人脂肪干细胞体外扩增方法。
Bioengineering (Basel). 2020 Jul 20;7(3):77. doi: 10.3390/bioengineering7030077.
10
The Progression of Regenerative Medicine and its Impact on Therapy Translation.再生医学的进展及其对治疗转化的影响。
Clin Transl Sci. 2020 May;13(3):440-450. doi: 10.1111/cts.12736. Epub 2020 Feb 6.